JAK2 and bone cancer: Recent studies have suggested that the JAK2/STAT3 pathway is abnormally activated in different forms of chronic pain, including neuropathic pain [4,11,14,21-23], inflammatory pain [3, 7, 24, 25], morphine tolerance[4] and bone cancer pain [8, 26, 27].